Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 563-574

  Galve de Rochemonteix, Béatrix ^d   Kobayashi, Toshihide ^a   Rosnoblet, Corinne ^d   Lindsay, Margaret ^d   Parton, Robert G ^d   Reber, Guido ^d   De Maistre, Emmanuel ^b   Wahl, Denis ^b   Kruithof, Egbert K O ^d   Gruenberg, Jean ^a   De Moerloose, Philippe ^c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d NONE

Author keywords

Anti phospholipid antibodies; Human endothelial cells; Late endosomes; Lysobisphosphatidic acid; 32 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSOME; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MEMBRANE BINDING; PRIORITY JOURNAL;

EID: 0006633639     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.20.2.563     Document Type: Article

References (32)

1. Cines DB, McCrae KR. The antiphospholipid-protein syndrome. J Clin Immunol. 1995;15:86S-100S.
2. Rauch J, Janoff AS. Antibodies against phospholipids other than cardiolipin: potential roles for both phospholipid and protein. Lupus. 1996;5: 498-502.
3. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 1996;39:1444-1454.
4. Kandiah DA, Sali A, Sheng Y, Victoria EJ, Marquis DM, Coutts SM, Krilis SA. Current insights in the 'antiphospholipid' syndrome: clinical, immunological, and molecular aspects. Adv Immunol. 1998;70:507-563.
5. Bakimer R, Shoenfeld Y. Pathogenesis of the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, eds. The Antiphospholipid Syndrome. Boca Raton, Fla: CRC Press; 1996:59.
6. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost. 1996;75:536-541.
7. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am. 1997;81:151-177.
8. Meroni PL, del Papa N, Gambini D, Tincani A, Balestrieri G. Antiphospholipid antibodies and endothelial cells: an unending story. Lupus. 1995;4:169-171.
9. Roubey RAS. Mechanisms of autoantibody-mediated thrombosis. Lupus. 1998;7(suppl 2):S114-S119.
10. Simantov R, La Sala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest. 1995;96:2211-2219.
11. Rand JH, Wu XX, Andree HA, Ross JB, Rusinova E, Gascon-Lema MG, Calandri C, Harpel PC. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a 'lupus procoagulant' phenomenon. Blood. 1998;92:1652-1660.
12. Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J Clin Invest. 1998;101:1951-1959.
13. Pötzsch B, Kawamura H, Preissner KT, Schmidt M, Seelig C, Muller-Berghaus G. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. J Lab Clin Med. 1995;125:56-65.
14. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG, Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature. 1998;392:193-197.
15. Rojo M, Pepperkok R, Emery G, Kellner R, Parton RG, Gruenberg J. Involvement of the transmembrane protein p23 in biosynthetic protein transport. J Cell Biol. 1997;139:1119-1135.
16. 2-glycoprotein I. Br J Haematol. 1992;81:568-573.
17. Reber G, Tremblet C, Bernard C, Mermillod B, de Moerloose P. Anticardiolipin antibodies and thrombosis: buffer's influence on the detection and quantitation of anticardiolipin measured by ELISA. Thromb Res. 1990;57:215-226.
18. Jaffe EA, Nachman RI, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
19. Griffiths G, McDowell A, Back R, Dubochet J. On the preparation of cryosections for immunocytochemistry. J Ultrastruct Res. 1984;89:65-78.
20. Kornfeld S. Structure and function of the mannose-6-phosphate/ insulin-like growth factor II receptors. Annu Rev Biochem. 1992;62: 307-330.
21. Ikematsu W, Luan F-L, La Rosa L, Beltrami B, Nicoletti F, Buyon JP, Meroni PL, Balestrieri G, Casali P. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in Balb/c mice. Arthritis Rheum. 1998;41:1026-1039.
22. Horkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest. 1996;98: 815-825.
23. 2-glycoprotein I mediates the antibody binding to endothelial membranes and induce the expression of adhesion molecules. Clin Exp Rheumatol. 1995;13:179-185.
24. 2,-glycoprotein I and induce endothelial activation. Arthritis Rheum. 1997;40:551-561.
25. 2-glycoprotein 1 antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation. 1998;97:900-906.
26. 2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood. 1998;91:1999-2004.
27. Rao LV, Hoang AD, Rapaport SI. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood. 1996;88:4173-4182.
28. Branch DW, Rodgers GM. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol. 1993;168:206-210.
29. Shibata S, Harpel PC, Gharavi A, Rand JH, Fillit H. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood. 1994;83: 2532-2540.
30. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today. 1996;17: 163-164.
31. 2-glycoprotein 1 in the antiphospholipid binding to endothelial cells. Lupus. 1995;4:179-186.
32. 2-glycoprotein I antibodies. J Immunol. 1998;160:5572-5578.